相关实验视频

Updated: May 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

可生物降解聚合物常利脱支架过度扩张的可行性:SYNOVER研究

Seung Hun Lee¹, Yong-Kyu Lee¹, Joon Ho Ahn¹

¹Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju.

Coronary artery disease

|April 23, 2025

概括

使用SYNERGY支架的光学连贯性断层扫描 (OCT) 引导的穿皮冠状动脉干预 (PCI) 对大冠状动脉是安全有效的,显示出最佳的支架扩张和良好的长期结果.

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学
医疗成像医学成像

背景情况:

穿皮冠状动脉干预 (PCI) 的进展仍然面临着与支架相关的并发症.
支架优化对于改善PCI结果至关重要.
可生物降解的聚合物恒利木斯排泄支架 (SYNERGY) 需要在大冠状动脉中进行评估.

研究的目的:

在大冠状动脉 (≥4.5毫米) 中研究过度扩张的SYNERGY支架的安全性和有效性.
用光学连贯断层扫描 (OCT) 指导来评估支架扩张和临床结果.

主要方法:

对接受PCI的缺血性心脏病患者进行单中心观察性研究.
在大冠状动脉 (≥4.5毫米) 中使用OCT指导放置SYNERGY支架.
使用扩张后的技术来实现最佳的支架扩张,OCT评估.

主要成果:

在PCI后分析了12名患者和8427名坚持者.
海外国与地区证实了足够的支架扩张 (最大直径4.5±0.2毫米,扩张113.2±4.1%).
没有观察到支架骨折或主要边缘剖析;在随访期间发生了一次心肌梗塞,没有支架血栓形成或死亡.

结论:

使用SYNERGY支架的OCT引导PCI对于大冠状动脉是安全有效的.
这种方法促进了最佳的支架扩张和有利的长期临床结果.
建议在复杂的解剖学情况下使用OCT引导的PCI,以证明SYNERGY在过度扩张下支架的性能.

关键词:

急性冠状动脉综合征是什么大冠状动脉的大冠状动脉光学连贯性断层扫描技术通过皮肤进行冠状动脉干预.

更多相关视频

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Published on: October 26, 2016

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

相关概念视频

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...